vs
EyePoint, Inc.（EYPT）与Seer, Inc.（SEER）财务数据对比。点击上方公司名可切换其他公司
Seer, Inc.的季度营收约是EyePoint, Inc.的6.8倍（$4.2M vs $619.0K）。Seer, Inc.净利率更高（-380.7% vs -10922.3%，领先10541.6%）。Seer, Inc.同比增速更快（5.0% vs -94.7%）。Seer, Inc.自由现金流更多（$-11.1M vs $-66.0M）。过去两年Seer, Inc.的营收复合增速更高（17.1% vs -77.0%）
EyePoint制药公司总部位于马萨诸塞州沃特敦，是一家专注于将微机电系统（MEMS）与纳米技术应用于给药领域的专业医药企业，依托前沿交叉技术开发创新给药方案，聚焦眼科等领域的药物递送技术创新与产品开发。
Seer, Inc.是一家总部位于美国加利福尼亚州雷德伍德城的生物技术企业，成立于2017年，专注于开发蛋白质组学研究领域的相关技术，目前在生物科研技术开发领域开展业务。
EYPT vs SEER — 直观对比
营收规模更大
SEER
是对方的6.8倍
$619.0K
营收增速更快
SEER
高出99.7%
-94.7%
净利率更高
SEER
高出10541.6%
-10922.3%
自由现金流更多
SEER
多$54.9M
$-66.0M
两年增速更快
SEER
近两年复合增速
-77.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $619.0K | $4.2M |
| 净利润 | $-67.6M | $-16.0M |
| 毛利率 | — | 52.0% |
| 营业利润率 | -11364.3% | -413.8% |
| 净利率 | -10922.3% | -380.7% |
| 营收同比 | -94.7% | 5.0% |
| 净利润同比 | -63.3% | 26.4% |
| 每股收益（稀释后） | $-0.82 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EYPTSEER
| Q4 25 | $619.0K | $4.2M | ||
| Q3 25 | $966.0K | $4.1M | ||
| Q2 25 | $5.3M | $4.1M | ||
| Q1 25 | $24.5M | $4.2M | ||
| Q4 24 | $11.6M | $4.0M | ||
| Q3 24 | $10.5M | $4.0M | ||
| Q2 24 | $9.5M | $3.1M | ||
| Q1 24 | $11.7M | $3.1M |
净利润EYPTSEER
| Q4 25 | $-67.6M | $-16.0M | ||
| Q3 25 | $-59.7M | $-18.2M | ||
| Q2 25 | $-59.4M | $-19.4M | ||
| Q1 25 | $-45.2M | $-19.9M | ||
| Q4 24 | $-41.4M | $-21.7M | ||
| Q3 24 | $-29.4M | $-21.3M | ||
| Q2 24 | $-30.8M | $-22.9M | ||
| Q1 24 | $-29.3M | $-20.7M |
毛利率EYPTSEER
| Q4 25 | — | 52.0% | ||
| Q3 25 | — | 51.2% | ||
| Q2 25 | — | 52.1% | ||
| Q1 25 | — | 49.0% | ||
| Q4 24 | — | 50.6% | ||
| Q3 24 | 93.0% | 48.1% | ||
| Q2 24 | 85.2% | 56.3% | ||
| Q1 24 | 93.5% | 44.4% |
营业利润率EYPTSEER
| Q4 25 | -11364.3% | -413.8% | ||
| Q3 25 | -6420.8% | -469.4% | ||
| Q2 25 | -1166.8% | -506.8% | ||
| Q1 25 | -199.7% | -493.0% | ||
| Q4 24 | -390.4% | -587.2% | ||
| Q3 24 | -311.2% | -603.3% | ||
| Q2 24 | -364.5% | -882.0% | ||
| Q1 24 | -285.2% | -821.7% |
净利率EYPTSEER
| Q4 25 | -10922.3% | -380.7% | ||
| Q3 25 | -6183.4% | -442.5% | ||
| Q2 25 | -1114.3% | -479.5% | ||
| Q1 25 | -184.8% | -474.4% | ||
| Q4 24 | -357.3% | -543.6% | ||
| Q3 24 | -279.0% | -529.0% | ||
| Q2 24 | -325.3% | -743.8% | ||
| Q1 24 | -250.6% | -674.5% |
每股收益（稀释后）EYPTSEER
| Q4 25 | $-0.82 | — | ||
| Q3 25 | $-0.85 | — | ||
| Q2 25 | $-0.85 | — | ||
| Q1 25 | $-0.65 | — | ||
| Q4 24 | $-0.65 | — | ||
| Q3 24 | $-0.54 | $-0.35 | ||
| Q2 24 | $-0.58 | $-0.35 | ||
| Q1 24 | $-0.55 | $-0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $306.1M | $47.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $306.1M | $259.3M |
| 总资产 | $364.0M | $296.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EYPTSEER
| Q4 25 | $306.1M | $47.3M | ||
| Q3 25 | $204.0M | $45.0M | ||
| Q2 25 | $255.7M | $37.9M | ||
| Q1 25 | $318.2M | $52.4M | ||
| Q4 24 | $370.9M | $40.8M | ||
| Q3 24 | $253.8M | $37.6M | ||
| Q2 24 | $280.2M | $31.9M | ||
| Q1 24 | $299.3M | $54.4M |
股东权益EYPTSEER
| Q4 25 | $306.1M | $259.3M | ||
| Q3 25 | $200.2M | $271.8M | ||
| Q2 25 | $246.0M | $288.3M | ||
| Q1 25 | $298.4M | $311.0M | ||
| Q4 24 | $336.5M | $327.6M | ||
| Q3 24 | $218.7M | $344.7M | ||
| Q2 24 | $228.3M | $364.7M | ||
| Q1 24 | $249.9M | $383.6M |
总资产EYPTSEER
| Q4 25 | $364.0M | $296.1M | ||
| Q3 25 | $251.7M | $308.6M | ||
| Q2 25 | $301.1M | $322.5M | ||
| Q1 25 | $362.6M | $347.3M | ||
| Q4 24 | $418.5M | $366.6M | ||
| Q3 24 | $300.9M | $383.4M | ||
| Q2 24 | $324.2M | $406.6M | ||
| Q1 24 | $329.2M | $422.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-65.0M | $-10.8M |
| 自由现金流经营现金流 - 资本支出 | $-66.0M | $-11.1M |
| 自由现金流率自由现金流/营收 | -10667.7% | -264.2% |
| 资本支出强度资本支出/营收 | 159.3% | 7.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-243.4M | $-46.2M |
8季度趋势，按日历期对齐
经营现金流EYPTSEER
| Q4 25 | $-65.0M | $-10.8M | ||
| Q3 25 | $-59.4M | $-7.6M | ||
| Q2 25 | $-62.6M | $-14.7M | ||
| Q1 25 | $-53.1M | $-11.4M | ||
| Q4 24 | $-35.8M | $-11.5M | ||
| Q3 24 | $-39.0M | $-14.1M | ||
| Q2 24 | $-20.2M | $-10.1M | ||
| Q1 24 | $-31.2M | $-10.5M |
自由现金流EYPTSEER
| Q4 25 | $-66.0M | $-11.1M | ||
| Q3 25 | $-60.2M | $-7.8M | ||
| Q2 25 | $-63.8M | $-15.2M | ||
| Q1 25 | $-53.4M | $-12.1M | ||
| Q4 24 | $-36.2M | $-12.0M | ||
| Q3 24 | $-40.6M | $-16.3M | ||
| Q2 24 | $-21.1M | $-11.2M | ||
| Q1 24 | $-32.4M | $-11.2M |
自由现金流率EYPTSEER
| Q4 25 | -10667.7% | -264.2% | ||
| Q3 25 | -6226.9% | -190.5% | ||
| Q2 25 | -1196.5% | -375.9% | ||
| Q1 25 | -218.4% | -287.1% | ||
| Q4 24 | -312.7% | -299.8% | ||
| Q3 24 | -385.8% | -404.7% | ||
| Q2 24 | -222.4% | -366.0% | ||
| Q1 24 | -277.0% | -365.6% |
资本支出强度EYPTSEER
| Q4 25 | 159.3% | 7.0% | ||
| Q3 25 | 82.6% | 6.9% | ||
| Q2 25 | 22.9% | 14.0% | ||
| Q1 25 | 1.1% | 15.6% | ||
| Q4 24 | 3.3% | 13.4% | ||
| Q3 24 | 15.0% | 54.4% | ||
| Q2 24 | 9.5% | 38.2% | ||
| Q1 24 | 10.2% | 24.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
